Form 4 for ONCY ONCOLYTICS BIOTECH INC
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001493152-26-006548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-13 | 2026-02-11+ | ONCY | Seizinger Bernd R. | Dir | P - Purchase | $0.838 | +100.0K | 567.0K | +21% | +$83.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-02-11 | P | A | 60,000 | $0.83 | 526,991 | D | — | — | |
| 2 | Common | Common Shares | 2026-02-12 | P | A | 40,000 | $0.85 | 566,991 | D | — | — |